A Multicentric, Randomized, Open Label Study on Comparison of Pancreatic Beta Cell Recovery and Preservation in Type 2 Diabetic Patients Treated With DPP-4 Inhibitor (Vildagliptin) and Metformin
Latest Information Update: 17 Sep 2021
At a glance
- Drugs Vildagliptin (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 16 Jun 2020 Results presented at the 80th Annual Scientific Sessions of the American Diabetes Association.
- 01 Apr 2019 Status changed from active, no longer recruiting to completed.
- 09 Nov 2017 Planned primary completion date changed from 1 Oct 2018 to 1 Nov 2017.